Norman C. Selby's most recent trade in Infinity Pharmaceuticals Inc. was a trade of 45,000 Stock Option(right to buy) done . Disclosure was reported to the exchange on June 16, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Infinity Pharmaceuticals Inc. | Norman C. Selby | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 45,000 | 45,000 | - | - | Stock Option(right to buy) | |
| Infinity Pharmaceuticals Inc. | Norman C. Selby | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 10,000 | 10,000 | - | - | Stock Option(right to buy) | |
| Infinity Pharmaceuticals Inc. | Norman C. Selby | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Infinity Pharmaceuticals Inc. | Norman C. Selby | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| Infinity Pharmaceuticals Inc. | Norman C. Selby | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.92 per share. | 14 May 2021 | 5,000 | 15,000 (0%) | 0% | 0.9 | 4,600 | Common Stock |
| Infinity Pharmaceuticals Inc. | Norman C. Selby | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 May 2021 | 5,000 | 35,000 | - | - | Stock Option (right to buy) |